Haoxi Health Technology Limited (HAO)
NASDAQ: HAO · Real-Time Price · USD
0.196
+0.022 (12.43%)
Nov 7, 2024, 11:23 AM EST - Market open

Haoxi Health Technology Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jun '24 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
48.5248.5228.2316.1612.85
Revenue Growth (YoY)
71.88%71.88%74.72%25.76%-
Cost of Revenue
45.7745.7726.1715.5112.24
Gross Profit
2.752.752.060.650.61
Selling, General & Admin
0.950.950.810.280.21
Research & Development
0.080.080.060.10.06
Operating Expenses
1.031.030.870.380.28
Operating Income
1.721.721.20.270.33
Interest Expense
-0.04-0.04-0.02-0.01-0
Interest & Investment Income
0.080.08---
Other Non Operating Income (Expenses)
-0.02-0.020.020-0
Pretax Income
1.741.741.190.260.33
Income Tax Expense
0.440.440.220.020.02
Net Income
1.291.290.970.240.3
Net Income to Common
1.291.290.970.240.3
Net Income Growth
33.20%33.20%296.49%-19.56%-
Shares Outstanding (Basic)
3131282525
Shares Outstanding (Diluted)
3131282525
Shares Change (YoY)
10.82%10.82%10.45%--
EPS (Basic)
0.040.040.040.010.01
EPS (Diluted)
0.040.040.040.010.01
EPS Growth
20.20%20.20%258.97%-19.56%-
Free Cash Flow
-0.8-0.8-0.92-0.682.65
Free Cash Flow Per Share
-0.03-0.03-0.03-0.030.11
Gross Margin
5.67%5.67%7.30%4.02%4.71%
Operating Margin
3.54%3.54%4.24%1.66%2.57%
Profit Margin
2.66%2.66%3.44%1.51%2.37%
Free Cash Flow Margin
-1.65%-1.65%-3.25%-4.23%20.59%
EBITDA
1.731.731.20.270.33
EBITDA Margin
3.56%3.56%4.27%1.68%2.58%
D&A For EBITDA
0.010.010.0100
EBIT
1.721.721.20.270.33
EBIT Margin
3.54%3.54%4.24%1.66%2.57%
Effective Tax Rate
25.56%25.56%18.54%5.78%6.52%
Source: S&P Capital IQ. Standard template. Financial Sources.